Natixis Advisors L.P. Has $118.58 Million Stock Holdings in The Cigna Group (NYSE:CI)

Natixis Advisors L.P. boosted its stake in shares of The Cigna Group (NYSE:CI) by 0.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 396,007 shares of the health services provider’s stock after buying an additional 3,354 shares during the period. Natixis Advisors L.P.’s holdings in The Cigna Group were worth $118,584,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in CI. Roman Butler Fullerton & Co. raised its position in The Cigna Group by 61.4% in the 4th quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock valued at $2,772,000 after buying an additional 3,539 shares during the last quarter. Ellsworth Advisors LLC bought a new stake in shares of The Cigna Group in the fourth quarter worth $4,377,000. Sapient Capital LLC bought a new position in The Cigna Group in the fourth quarter valued at $2,811,000. Allspring Global Investments Holdings LLC increased its stake in The Cigna Group by 29.5% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 293,438 shares of the health services provider’s stock valued at $87,870,000 after buying an additional 66,891 shares during the last quarter. Finally, Accurate Wealth Management LLC bought a new stake in The Cigna Group during the 4th quarter worth about $2,244,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CI shares. Barclays initiated coverage on The Cigna Group in a report on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 price objective for the company. Royal Bank of Canada raised The Cigna Group from a “sector perform” rating to an “outperform” rating and boosted their price target for the stock from $327.00 to $354.00 in a research report on Monday, February 5th. Sanford C. Bernstein upgraded The Cigna Group from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $330.00 to $372.00 in a research note on Thursday, January 4th. Wells Fargo & Company raised their target price on shares of The Cigna Group from $334.00 to $348.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 6th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of The Cigna Group from a “hold” rating to a “buy” rating and boosted their target price for the stock from $355.00 to $370.00 in a report on Thursday, February 1st. Two equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $362.14.

Insider Activity at The Cigna Group

In other The Cigna Group news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $330.48, for a total transaction of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares in the company, valued at approximately $694,668.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other The Cigna Group news, CEO David Cordani sold 38,065 shares of the firm’s stock in a transaction on Friday, February 9th. The stock was sold at an average price of $335.22, for a total transaction of $12,760,149.30. Following the transaction, the chief executive officer now owns 329,321 shares in the company, valued at approximately $110,394,985.62. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the company’s stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the sale, the senior vice president now owns 2,102 shares of the company’s stock, valued at $694,668.96. The disclosure for this sale can be found here. Insiders sold 114,144 shares of company stock worth $39,296,330 in the last ninety days. 0.60% of the stock is owned by company insiders.

The Cigna Group Stock Performance

Shares of NYSE:CI traded down $11.16 on Thursday, hitting $346.02. The company had a trading volume of 1,392,269 shares, compared to its average volume of 1,562,761. The stock has a market cap of $101.16 billion, a price-to-earnings ratio of 20.53, a P/E/G ratio of 1.09 and a beta of 0.57. The stock has a 50 day moving average price of $350.78 and a 200 day moving average price of $319.21. The Cigna Group has a 1-year low of $240.50 and a 1-year high of $365.71. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.61.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 EPS for the quarter, beating analysts’ consensus estimates of $6.54 by $0.25. The business had revenue of $51.15 billion for the quarter, compared to analyst estimates of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The Cigna Group’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.96 EPS. Analysts expect that The Cigna Group will post 28.36 EPS for the current year.

The Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Tuesday, June 4th will be issued a dividend of $1.40 per share. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a $5.60 annualized dividend and a yield of 1.62%. The Cigna Group’s payout ratio is currently 32.20%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.